The 600-ton Norfloxacin raw material project of Kangwei Pharmaceutical has passed the current environmental impact assessment.
Release time:
2016-12-24
Source:
Xinhua
This report: The 600-ton norfloxacin raw material project of Kangwei Pharmaceutical recently passed the current environmental impact assessment by the Municipal Environmental Protection Science Design Research Institute.
On November 30, 2016, a seven-member evaluation and acceptance team composed of leaders from the municipal and county environmental protection bureaus and relevant experts inspected the current environmental impact of our company's 600-ton norfloxacin raw material project. Chief Engineer Wang Shaoguang and other company leaders warmly received the inspection team and together visited the second plant of Kangwei Pharmaceutical.
During the inspection, Lu Jianfeng, the director of the second plant of Kangwei Pharmaceutical, led the inspection team into the workshop and provided detailed introductions to the drug production processes, techniques, and environmental protection measures. As the experts listened to the presentations, they raised substantive questions, which Director Lu answered one by one.
After the inspection, the expert group carefully listened to the project report from the Municipal Environmental Protection Science Design Research Institute. They assessed the current environmental impact of the 600-ton norfloxacin raw material project of Kangwei Pharmaceutical and approved a series of related evaluation reports.
Related Documents
Copyright of the page©Xinxiang Xinya Paper Group Co., Ltd.
-
Marketing call:0373-5699898Fax: 0373-5699888 E-mail:xyxpaper@163.comAddress: Henan Xinxiang 107 National Highway 686km away
